In line with the in vitro data, inhibition of NFκB activation reduced tumor cell proliferation and attenuated the growth advantage conferred by STEAP4 expression in the xenograft model (Supplementary Fig. 4f, g). This evidence concerns the gene NFKB1 and neoplasm.